Anthera Pharmaceuticals, Inc. ANTH
Set alert
0.00 USD 0.00 0.00%
At close · Oct 30
0.0001 Day range 0.0001
0.00 52-week range 0.001
- YTD
- 0.00%
- 1 year
- 0.00%
- Open
- 0.0001
- Prev close
- 0.0001
- Mkt cap
- 2.62K
- Vol
- 23.89K
- Avg vol
- 1.20K
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.0001
- High
- 0.0001
- Forward P/E
- -0.04
- Beta
- 2.27
- Short ratio
- 2.09
- Inst. own
- 4.11%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.072222
- 200-d avg
- 0.139645
- 1y target
- 3.00
Analyst view
Consensus: buy
Buy
Price target (mean) 3.00
Ratings (0m) 5 2 buy · 3 hold · 0 sell
- Strong buy0
- Buy2
- Hold3
- Sell0
- Strong sell0
Recommendation trend
- This month 5
- 1 month ago 5
- 2 months ago 4
- 3 months ago 4
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.00 | 0.00 – 0.00 | 0.03 | 0.0% | 0 | 0.0% | 0 |
| Next quarter | 0.00 | 0.00 – 0.00 | -0.58 | 0.0% | 0 | 0.0% | 0 |
| Current year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Next year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 4.78M | 0.0% | 0 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Feb 20, 2018 | Roth Capital | Initiated | — | Buy |
| Dec 28, 2016 | Jefferies | Downgrade | — | Hold |
| Dec 28, 2016 | Citigroup | Downgrade | — | Neutral |
| Sep 16, 2015 | Citigroup | Initiated | — | Buy |
| May 11, 2015 | Citigroup | Upgrade | — | Neutral |
| Mar 4, 2013 | Jefferies | Initiated | — | Buy |
| Jun 28, 2012 | Citigroup | Downgrade | — | Sell |
| Jun 28, 2012 | Ascendiant Capital | Downgrade | — | Neutral |
| May 31, 2012 | Ascendiant Capital | Initiated | — | Buy |
| Mar 14, 2012 | Auriga | Downgrade | — | Sell |
| Mar 11, 2012 | Citigroup | Downgrade | — | Neutral |
| Mar 1, 2012 | Summer Street | Initiated | — | Buy |